SCHEMBL31642200

SCHEMBL31642200

CNC(CCCCCN)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.54
GSR P00390 1/20 0.50
SLC6A5 Q9Y345 1/20 0.49
CPB2 Q96IY4 7/20 0.48
RNPEP Q9H4A4 1/20 0.48
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
SIRT6 Q8N6T7 1/20 0.43
SIRT1 Q96EB6 1/20 0.43
TLR2 O60603 1/20 0.42
GNAI3 P08754 1/20 0.40
GNAO1 P09471 1/20 0.40
GNAI1 P63096 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
PLG P00747 1/20 0.40
LMNA P02545 1/20 0.40
THRB P10828 1/20 0.40
ALOX15 P16050 1/20 0.40
SLC6A2 P23975 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30360538 1.00 FOLH1 (0.54) FOLH1GSRSLC6A5CPB2RNPEP
SCHEMBL168589 0.98 FOLH1 (0.56) FOLH1GSRSLC6A5CPB2RNPEP
SCHEMBL164121 0.98 FOLH1 (0.56) FOLH1GSRSLC6A5CPB2RNPEP
SCHEMBL165084 0.98 FOLH1 (0.56) FOLH1GSRSLC6A5CPB2RNPEP
Hydrochloric Acid SCHEMBL25283310 0.96 FOLH1 (0.54) FOLH1GSRSLC6A5CPB2RNPEP
Methane SCHEMBL15135721 0.96 FOLH1 (0.54) FOLH1GSRSLC6A5CPB2RNPEP
Methane SCHEMBL15135720 0.96 FOLH1 (0.54) FOLH1GSRSLC6A5CPB2RNPEP
Hydrochloric Acid SCHEMBL2844807 0.96 FOLH1 (0.54) FOLH1GSRSLC6A5CPB2RNPEP
Hydrochloric Acid SCHEMBL8332033 0.96 FOLH1 (0.54) FOLH1GSRSLC6A5CPB2RNPEP
Bromide SCHEMBL6933931 0.96 FOLH1 (0.54) FOLH1GSRSLC6A5CPB2RNPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250222146-A1 Radiopharmaceuticals Targeting Somatostatin Receptor 2 and Uses Thereof RAYZEBIO, INC. (US) 2025-07-10 US disclosed
WO-2025137441-A1 RADIOPHARMACEUTICALS TARGETING SOMATOSTATIN RECEPTOR 2 AND USES THEREOF RAYZEBIO, INC. (US) 2025-06-26 WO disclosed
WO-2025137443-A1 RADIOPHARMACEUTICAL COMPOSITIONS TARGETING SOMATOSTATIN RECEPTORS AND USES THEREOF RAYZEBIO, INC. (US) 2025-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250222146-A1 Radiopharmaceuticals Targeting Somatostatin Receptor 2 and Uses Thereof SSTR2, SSTR4, SSTR5 FOLH1 19/4885GSR 2461/4885SLC6A5 2085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.